Clinical & Experimental Immunology · 2002 · 62 citations · 35 references
Life SciencesDermatologyImmunologyAutoimmunityCellular ImmunologyImmunopathologyAutoimmune DiseasesAutoimmune Skin DiseasesImmunopathology Of SkinNatural Killer Cell BiologyNatural Killer Cell FunctionT Cell BiologyHyperproliferative Skin DiseaseNaive T CellsNatural Killer Cell ImmunophenotypesPeripheral Blood Lymphocyte AnalysisPeripheral Blood Natural Killer CellsPsoriasis ImmunopathologyPsoriatic DiseaseT Helper Cells
Psoriasis is a chronic, inflammatory, hyperproliferative skin disease, in which autoimmunity plays a great role. Natural killer T cells (NK T cells), are suggested to be involved in the pathogenesis of different autoimmune diseases. To examine the involvement of CD3+CD56+ NK T cells in the pathogenesis of psoriasis, we investigated the lymphocyte subpopulations obtained from blood samples of psoriatic patients before and after treatment, and of healthy controls, using two-colour flow cytometry. We found no significant differences between total T cells, total B cells, T helper cells, T cytotoxic cells and NK cells in patients with psoriasis before and after treatment and in controls. Increased percentage of memory T cells and decreased percentage of naive T cells was detected in psoriatic patients compared to controls, but these changes were not statistically significant. The CD3+CD56+ cells of psoriatic patients were significantly decreased relative to controls. The percentage of CD3+CD56+ cells increased after different antipsoriatic therapies, but remained significantly lower than those found in controls. CD3+CD56+ cells of healthy controls were capable of rapid activation, while in psoriatic patients activated NK T cells were almost absent. The decrease in the number of CD3+CD56+ cells may represent an intrinsic characteristic feature of patients with psoriasis, which is supported by the fact that after treatment NK T cells do not reach the values found in controls. In conclusion our results suggest that CD3+CD56+ NK T cells could be actively involved in the development of Th1 mediated autoimmune diseases.
35
Olivier Lantz, Albert Bendelac · The Journal of Experimental Medicine · 1994 · 1K citations · Full text
Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
S. Brian Wilson, Sally C. Kent, Kurt T. Patton et al. · Nature · 1998 · 641 citations
Lisa M. Austin, Maki Ozawa, Toyoko Kikuchi et al. · Journal of Investigative Dermatology · 1999 · 483 citations · Full text
Medicine, Dermatology, Immunology +17
T Cells Involved in Psoriasis Vulgaris Belong to the Th1 Subset
Michael Buslau, Wolfram Jochum, E Hermann et al. · Journal of Investigative Dermatology · 1994 · 461 citations